Richard Mather

Richard Mather is a seasoned professional who has held key roles in the pharmaceutical industry, including as a Senior Group Director of Clinical Projects at AstraZeneca since 2019. Prior to this role, they served as a Director in Global Study Management at Amgen from 2006 to 2014, and as an Associate Director/Director at GlaxoSmithKline from 1999 to 2006. Earlier in their career, Richard was a Clinical Scientist and Global Clinical Leader in Oncology at Novartis from 1995 to 1999, and was a Clinical Investigation Manager at Cyanamid International from 1989 to 1995.